DIA 2020 Global Annual Meeting

Interest continues to increase in harnessing technology solutions to reduce the cost of clinical trials, accelerate and diversify patient recruitment, and streamline processes perceived as burdensome or artificial by patients and site staff. With the number of marketed digital trial solutions growing rapidly, study designers and clinical operations professionals need a better understanding of the fundamental trial processes that can benefit from digital innovations. This session identifies numerous areas in clinical study operations, from study approval through close-out, with potential impact from digital innovation. It also identifies considerations for when digital enhancements may or may not be useful, as well as which elements of clinical operations may actually interfere with digital innovation.